UKAS accreditedlabs
Clinically-validatedtests
Experienced scientific& clinical team
UKAS accreditedlabs
Clinically-validatedtests
Experienced scientific& clinical team
Driving the futureof preventative healthcare
Hurdle is the only company in the world that combines deep biomarker R&D expertise with the power of Diagnostics-as-a-Service (DaaS) to launch novel diagnostics: from conception to global scale. We live and breathe innovation.
We have authored three patents for our work around epigenetics and developed the world’s first saliva-based NGS epigenetic biomarker for biological age and the first CE-marked saliva-based COVID-19 PCR test.
Our scientific focus areas are:
- Biomarker research & development – discovering novel biomarkers for complex risk factors and diseases using multi-omics datasets and deploying them in cost-effective platforms.
- Epigenetics and machine-learning – pushing the boundaries of DNA methylation based biomarkers, which are able to quantify the effects of genetics and lifestyle at the molecular level.
Driving the futureof preventative healthcare
Hurdle is the only company in the world that combines deep biomarker R&D expertise with the power of Diagnostics-as-a-Service (DaaS) to launch novel diagnostics: from conception to global scale. We live and breathe innovation.
We have authored three patents for our work around epigenetics and developed the world’s first saliva-based NGS epigenetic biomarker for biological age and the first CE-marked saliva-based COVID-19 PCR test.
Our scientific focus areas are:
- Biomarker research & development – discovering novel biomarkers for complex risk factors and diseases using multi-omics datasets and deploying them in cost-effective platforms.
- Epigenetics and machine-learning – pushing the boundaries of DNA methylation based biomarkers, which are able to quantify the effects of genetics and lifestyle at the molecular level.
We have been working with the Hurdle team for over 2 years now on the co-development of novel diagnostics. We are really excited to leverage their biomarker R&D and DaaS capabilities to complement our future consumer propositions by offering consumers health and wellness tests rooted in cutting edge science.
Karl Wishart
Global R&D Emerging Science & Innovation Director at Bayer Consumer Health
For us to deliver clinical trials in new ways requires innovative partners. We've been delighted to partner with Hurdle on trials investigating treatments for everything from pre-diabetes to flu. They understand the needs of health tech pioneers and are an incredible team to work with!
Michael Young
Co-Founder at Lindus Health
We have been working with the Hurdle team for over 2 years now on the co-development of novel diagnostics. We are really excited to leverage their biomarker R&D and DaaS capabilities to complement our future consumer propositions by offering consumers health and wellness tests rooted in cutting edge science.
Karl Wishart
Global R&D Emerging Science & Innovation Director at Bayer Consumer Health
For us to deliver clinical trials in new ways requires innovative partners. We've been delighted to partner with Hurdle on trials investigating treatments for everything from pre-diabetes to flu. They understand the needs of health tech pioneers and are an incredible team to work with!
Michael Young
Co-Founder at Lindus Health
Laboratory testingyou can trust
The accuracy and validity of a test result is vital. That’s why each laboratory we use to process samples is registered with the Care Quality Commission (CQC) and accredited by the United Kingdom Accreditation Service (UKAS). This means they must continually meet stringent internal and external quality control protocols.
Furthermore, our expert team carefully vets and maintains a close ongoing relationship with each lab partner in our network, so you can be sure of the highest testing standards.
Laboratory testingyou can trust
The accuracy and validity of a test result is vital. That’s why each laboratory we use to process samples is registered with the Care Quality Commission (CQC) and accredited by the United Kingdom Accreditation Service (UKAS). This means they must continually meet stringent internal and external quality control protocols.
Furthermore, our expert team carefully vets and maintains a close ongoing relationship with each lab partner in our network, so you can be sure of the highest testing standards.
At-home sample collection that meets clinical standards
Quality and accuracy are essential when it comes to health testing. Therefore, the at-home sample collection methods we develop and use are validated against conventional methods to meet strict standards for accuracy and reliability.
Our sample collection kits are UKCA and CE-marked, meaning they meet health and safety requirements within the European Economic Area (EEA), and are accredited as medical devices under ISO 13485. We cover specimen types across venous blood, capillary blood (finger prick and upper arm devices), saliva, urine, stool, nasal swabs, vaginal swabs and many more.
At-home sample collection that meets clinical standards
Quality and accuracy are essential when it comes to health testing. Therefore, the at-home sample collection methods we develop and use are validated against conventional methods to meet strict standards for accuracy and reliability.
Our sample collection kits are UKCA and CE-marked, meaning they meet health and safety requirements within the European Economic Area (EEA), and are accredited as medical devices under ISO 13485. We cover specimen types across venous blood, capillary blood (finger prick and upper arm devices), saliva, urine, stool, nasal swabs, vaginal swabs and many more.
Experts at every step of the process
Hurdle was founded by leading scientists from Cambridge and Oxford universities, who spent their academic careers focusing on preventative healthcare, epigenetics of ageing, computational biology and novel omics technologies. They combine their expertise with experienced medical doctors and operations specialists to oversee each stage of the diagnostic testing process, including which biomarkers to test and the best scientific methods for each.
Tom Stubbs, PhD
Tom has a background in cellular biochemistry, molecular biology, and epigenetics. With his extensive background, he co-founded Hurdle with a mission of helping more people access the health benefits of biological testing.
Dani Martin-Herranz, PhD
Dani leads the science team and biomarker R&D at Hurdle. He is an expert in computational biology, epigenetics, ageing, biomarker discovery and in vitro diagnostics (IVDs).
Dr Adam Abbs
Adam is an NHS-trained GP with a special interest in telemedicine. He has extensive experience of delivering safe, effective and efficient medical care remotely through the use of novel technologies.
Toby Call, PhD
Toby has a background in synthetic biology and a PhD in industrial biotechnology and biochemistry. He works with operations, product, science, and medical teams to bring biomarker solutions to life in R&D and diagnostics settings.
Lisa Schmunk, PhD
Lisa holds a PhD in Integrative Genomics/Public Health and Primary Care from Cambridge University and has worked on epigenetics and genetics projects since 2013. At Hurdle, she uses her expertise to develop and implement novel complex biomarkers.
Felice Leung, PhD
Felice holds a PhD in Renal Physiology from UCL and 6 years of R&D experience in the diagnostics industry. At Hurdle, she designs and develops bespoke diagnostic solutions for clients.
Hira Javaid, PHD
Hira is an R&D Scientist at Hurdle, with a special focus on DNA methylation and biomarker discovery through bioinformatics tools. Hira completed her PhD in Oncology at the University of Oxford, using machine learning to develop a DNA methylation biomarker for early cancer detection for renal and pancreatic cancer. Hira is also an avid juggler, Youtuber, and admissions coach.
Constantin Petrescu, PHD
Constantin Cezar Petrescu holds a PhD in Computer Science, specialising in Program Analysis and Data-Driven Analysis. He has extensive experience in machine learning, program analysis, and information security. At Hurdle, Constantin contributes to the development of innovative AI-powered health solutions.
Academic papers featuring the Hurdle team
Article
Screening for genes that accelerate the epigenetic aging clock in humans reveals a role for the H3K36 methyltransferase NSD1
Genome Biology, August 2019